|Printable version||E-mail this to a friend|
Lumpy skin disease outbreaks contained in south-east Europe
The mass vaccination of cattle implemented in south-eastern Europe successfully contained the outbreaks of lumpy skin disease in the region in 2015-16. This is the main conclusion of an epidemiological analysis carried out by EFSA in cooperation with countries affected by the disease and those at risk.
This report follows EFSA’s scientific advice published in August 2016, recommending vaccination to minimise the number of lumpy skin disease outbreaks in regions already affected or at risk.
“Despite the difficult epidemiological situation, all countries involved in the data collection have shown a high level of commitment and cooperation,” said Alessandro Broglia, veterinarian at EFSA.
Closeness to affected farms and warm temperatures resulting in a higher presence of the insects that transmit the disease are among the factors responsible for the spread of the disease.
Experts made recommendations on how to improve data collection and analysis. They also recommended laboratory confirmation of suspected cases in vaccinated animals to differentiate the strains.
A disease of cattle
Lumpy skin disease is an infectious disease of cattle, which causes economic losses and occasionally is fatal. It is characterised by skin nodules.
It was previously limited to southern and eastern Africa. After it was confirmed in Turkey in 2013, the virus spread through south-eastern Europe. As of 2016 the disease was detected in seven European countries – Greece, Bulgaria, the Former Yugoslav Republic of Macedonia, Serbia, Albania, Montenegro, and Kosovo.
To produce this report EFSA experts worked with competent authorities of Greece, Bulgaria, Albania, Serbia, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Montenegro, Turkey, Romania, Croatia, and Kosovo. Further scientific advice will be provided at the beginning of 2018.
 This designation is without prejudice to positions on status, and is in line with UNSCR 1244 and the ICJ Opinion on the Kosovo Declaration of Independence.
Latest News from
EU scales up its assistance against cholera outbreak in Yemen26/06/2017 16:05:00
The EC is scaling up its response to an unprecedented cholera outbreak in Yemen with an additional €5m, bringing total EU support for efforts to tackle the disease to €8.8m.
Investments in EU Transport: Commission proposes €2.7bn for 152 projects26/06/2017 15:15:15
Recently the European Commission proposed to invest €2.7 billion in 152 key transport projects that support competitive, clean and connected mobility in Europe.
Europe’s shrinking middle class26/06/2017 14:25:00
In the follow blog piece, originally posted on Social Europe, Carlos Vacas-Soriano and Enrique Fernández-Macías look at evolution of household disposable real income levels over the period 2004-2013, and the broader phenomenon on Europe's shrinking middle class.
First ever guidance for stem cell therapies in animals published26/06/2017 13:10:00
Document gives advice on sterile manufacturing processes for veterinary stem cell medicines.
EMA recommends that Symbioflor 2 can continue to be used for irritable bowel syndrome26/06/2017 12:44:00
A review by the EMA has concluded that Symbioflor 2 and associated names can continue to be used for treatment of irritable bowel syndrome (IBS) in adults. However, the medicine should no longer be used more widely to treat so-called functional gastrointestinal disorders.